Unknown

Dataset Information

Prioritizing the worries of AML patients: Quantifying patient experience using best-worst scaling.


ABSTRACT:

Context

Although patients with acute myeloid leukemia (AML) experience significant toxicities and poor outcomes, few studies have quantified patients' experience.

Methods

A community-centered approach was used to develop an AML-specific best-worst scaling (BWS) instrument involving 13 items in four domains (psychological, physical, decision-making, and treatment delivery) to quantify patient worry. A survey of patients and caregivers was conducted using the instrument. Data were analyzed using conditional logistic regression.

Results

The survey was completed by 832 patients and 237 caregivers. Patients were predominantly white (88%), married/partnered (72%), and in remission (95%). The median age was 55 years (range: 19-87). Median time since diagnosis was 8 years (ra

SUBMITTER: Richardson DR 

PROVIDER: S-EPMC10246445 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature